This course has expired. You can still review the content but course credit is no longer available.
This certified CME activity is designed for anterior segment specialists and general ophthalmologists involved in the management of ocular disorders and diseases.
Sponsored with educational grants from the following:
Upon completion of this activity, the participant should be able to:
Identify recent advances in the diagnosis and treatment of eye diseases.
Identify major advanced in key areas of cutting-edge research and technology in ophthalmology.
Identify and integrate practice management strategies to address critical business and operational tasks in the ophthalmologist’s practice.
Formulate strategies to manage patients with Presbyopia and Astigmatism.
Identify best practices in Minimally Invasive Glaucoma Surgery (MIGS).
Implement the latest techniques in refractive surgery.
Identify recent clinical outcomes and components of today’s cataract surgery and technologies.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education LLC, the American College of Eye Surgeons (ACES), the American Board of Eye Surgery (ABES) and the Society for Excellence in Eyecare (SEE). Evolve Medical Education LLC is accredited by the ACCME to provide continuing medical education for physicians.
Evolve Medical Education, LLC this live activity for a maximum of 13.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Ophthalmologists, optometrists and allied health professionals face increasing pressure to remain current in their clinical knowledge, diagnostic skills and treatment selection due to shifting demographics and increasing numbers of aging patients.
These changes are of particular significance in the areas of refractive surgery, cataract surgical services, cornea services, and glaucoma management. As population trends lead to changes in ocular disease prevalence, ophthalmic development in pharmaceuticals and new medical device technology continues to change the treatment strategies available to clinicians and surgeons. Practice patterns are shifting as well, with practice management embracing the need for integrated management.
In the past 5 years alone, ophthalmology has seen the introduction of femtosecond lasers for cataract surgery, intraoperative aberrometry, enhanced depth of focus intraocular lenses, new IOL calculators, presbyopia-correcting IOLs and corneal inlays, micro-incisional glaucoma surgery (MIGS) and the devices associated with them, a bevy of diagnostic tools to better identify and quantify dry eye, the second dry eye pharmacologic treatment, software improvements on refractive lasers, small incision lenticule extraction (SMILE), and the U.S. approval of collagen corneal crosslinking (CXL).
Ongoing education about these innovations is necessary to provide eye care professionals with the best means to enhance patient outcomes.